Controversy over generic substitution

R.E. Ferner; Warren Lenney; John F. Marriott

doi:10.1136/bmj.c2548

Controversy over generic substitution

R.E. Ferner, Warren Lenney, John F. Marriott

Aston Pharmacy School

Research output: Contribution to journal › Article › peer-review

Abstract

Substitution of branded medicine with a generic equivalent is already common. Robin Ferner, Warren Lenney, and John Marriott argue that concerns about UK plans to let pharmacists make the decision are unwarranted.

Original language	English
Pages (from-to)	1341-1343
Number of pages	3
Journal	BMJ
Volume	340
Issue number	7760
DOIs	https://doi.org/10.1136/bmj.c2548
Publication status	Published - 1 Jun 2010

Access to Document

10.1136/bmj.c2548

Cite this

@article{1afd770b14ed4c8a91c0bb0f0c994207,

title = "Controversy over generic substitution",

abstract = "Substitution of branded medicine with a generic equivalent is already common. Robin Ferner, Warren Lenney, and John Marriott argue that concerns about UK plans to let pharmacists make the decision are unwarranted.",

author = "R.E. Ferner and Warren Lenney and Marriott, {John F.}",

year = "2010",

month = jun,

day = "1",

doi = "10.1136/bmj.c2548",

language = "English",

volume = "340",

pages = "1341--1343",

journal = "BMJ",

issn = "1759-2151",

publisher = "BMJ Publishing Group",

number = "7760",

}

TY - JOUR

T1 - Controversy over generic substitution

AU - Ferner, R.E.

AU - Lenney, Warren

AU - Marriott, John F.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Substitution of branded medicine with a generic equivalent is already common. Robin Ferner, Warren Lenney, and John Marriott argue that concerns about UK plans to let pharmacists make the decision are unwarranted.

AB - Substitution of branded medicine with a generic equivalent is already common. Robin Ferner, Warren Lenney, and John Marriott argue that concerns about UK plans to let pharmacists make the decision are unwarranted.

UR - http://www.scopus.com/inward/record.url?scp=77953722299&partnerID=8YFLogxK

UR - http://www.bmj.com/content/340/bmj.c2548

U2 - 10.1136/bmj.c2548

DO - 10.1136/bmj.c2548

M3 - Article

AN - SCOPUS:77953722299

SN - 1759-2151

VL - 340

SP - 1341

EP - 1343

JO - BMJ

JF - BMJ

IS - 7760

ER -

Controversy over generic substitution

Abstract

Access to Document

Other files and links

Fingerprint

Cite this